The context and implications of multimorbidity and polypharmacy for health care systems and patients will be addressed in a CHEPA seminar to be presented on February 21, 2018 by Dr. Dee Mangin, Professor and Associate Chair and Director of Research in McMaster University’s Faculty of Family Medicine.
In her presentation, titled Policy, Performance and Polypharmacy, Dr. Mangin will also discuss the influences of policy and structures such as pay for performance, as well as potential policy issues, stakeholders and solutions.
Dr. Mangin is the David Braley & Nancy Gordon Chair in Family Medicine at McMaster and a Professor and Director of Research at the University of Otago, Christchurch, New Zealand.
She sits on the Section of Researchers’ Council with the College of Family Physicians of Canada (CFPC) and is a member of the Integrated Patient Safety Action Plan Medication Safety Leads Group, Patients for Patient Safety Canada.
Before moving from New Zealand to Canada, Dee Mangin was the Director of the Primary Care Unit at the University of Otago, Christchurch, and Clinical Leader for Research Audit and Evaluation at the Pegasus Health Primary Healthcare Organisation.
She was a Ministerially appointed member of the New Zealand Pharmaceutical and Therapeutic Products Advisory Committee, PHARMAC. She is a Fellow of the Royal New Zealand College of General Practitioners, and in 2011 she received their Distinguished Service Medal.
The seminar will take place on Wednesday, February 21, from 12:30 to 1:30 p.m. in CRL-B119. All are welcome to attend.
If you are unable to attend in person you are welcome to participate remotely online, using WebEx. To join the seminar online, copy and paste the link below into your browser. The password is CHEPAseminar